| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | CIRBP RBM15B HNRNPA0 TARDBP ALYREF KHDRBS1 HNRNPA1 HNRNPA1L3 HNRNPAB METTL14 | 7.78e-08 | 694 | 32 | 10 | GO:0003729 |
| GeneOntologyMolecularFunction | histone H2AQ104 methyltransferase activity | 2.49e-06 | 2 | 32 | 2 | GO:1990259 | |
| GeneOntologyMolecularFunction | protein-glutamine N-methyltransferase activity | 7.46e-06 | 3 | 32 | 2 | GO:0036009 | |
| GeneOntologyMolecularFunction | histone H2A methyltransferase activity | 1.49e-05 | 4 | 32 | 2 | GO:0140940 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 2.16e-05 | 34 | 32 | 3 | GO:0008266 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 2.88e-05 | 111 | 32 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 3.29e-05 | 39 | 32 | 3 | GO:0008187 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 7.22e-05 | 276 | 32 | 5 | GO:0003730 | |
| GeneOntologyMolecularFunction | RNA methyltransferase activity | 1.67e-04 | 67 | 32 | 3 | GO:0008173 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 3.58e-04 | 213 | 32 | 4 | GO:0008168 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 4.33e-04 | 224 | 32 | 4 | GO:0016741 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 5.93e-04 | 103 | 32 | 3 | GO:0008276 | |
| GeneOntologyMolecularFunction | rRNA methyltransferase activity | 6.72e-04 | 24 | 32 | 2 | GO:0008649 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a rRNA | 7.29e-04 | 25 | 32 | 2 | GO:0140102 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 1.60e-03 | 37 | 32 | 2 | GO:0070717 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 1.87e-03 | 40 | 32 | 2 | GO:0042162 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.16e-03 | 43 | 32 | 2 | GO:0030280 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 2.59e-03 | 172 | 32 | 3 | GO:0008757 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 4.71e-03 | 64 | 32 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 5.77e-03 | 71 | 32 | 2 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.78e-03 | 229 | 32 | 3 | GO:0140993 | |
| GeneOntologyBiologicalProcess | RNA splicing | CIRBP RBM15B TARDBP ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPA1L3 RBM3 METTL14 | 5.50e-12 | 502 | 32 | 12 | GO:0008380 |
| GeneOntologyBiologicalProcess | RNA processing | CIRBP RBM15B HNRNPA0 TARDBP ALYREF FAM98A SFPQ FBLL1 HNRNPUL1 KHDRBS1 GAR1 ATXN1 HNRNPA1 HNRNPA1L3 FBL RBM3 METTL14 | 8.06e-12 | 1500 | 32 | 17 | GO:0006396 |
| GeneOntologyBiologicalProcess | mRNA processing | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPA1L3 RBM3 METTL14 | 1.63e-11 | 551 | 32 | 12 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | CIRBP RBM15B HNRNPA0 TARDBP ALYREF CNOT11 SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPA1L3 HNRNPAB RBM3 METTL14 | 2.38e-11 | 917 | 32 | 14 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | CIRBP RBM15B HNRNPA0 TARDBP CNOT11 KHDRBS1 HNRNPA1 HNRNPAB RBM3 METTL14 | 7.98e-10 | 443 | 32 | 10 | GO:1903311 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | CIRBP RBM15B SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPA1L3 RBM3 METTL14 | 2.55e-09 | 358 | 32 | 9 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | CIRBP RBM15B SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPA1L3 RBM3 METTL14 | 2.55e-09 | 358 | 32 | 9 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | CIRBP RBM15B SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPA1L3 RBM3 METTL14 | 2.81e-09 | 362 | 32 | 9 | GO:0000375 |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.35e-07 | 79 | 32 | 5 | GO:0000380 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.19e-07 | 87 | 32 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA modification | 2.67e-07 | 176 | 32 | 6 | GO:0009451 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 4.62e-07 | 101 | 32 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 8.81e-07 | 115 | 32 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | RNA localization | 9.12e-07 | 217 | 32 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nuclear transport | 1.49e-06 | 378 | 32 | 7 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 1.49e-06 | 378 | 32 | 7 | GO:0006913 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.56e-06 | 129 | 32 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | macromolecule methylation | 2.77e-06 | 145 | 32 | 5 | GO:0043414 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.22e-06 | 158 | 32 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 5.96e-06 | 77 | 32 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | CIRBP HNRNPA0 TARDBP POU3F1 FAM98A GDF7 KHDRBS1 HNRNPA1 HNRNPAB RBM3 METTL14 | 6.31e-06 | 1446 | 32 | 11 | GO:0010628 |
| GeneOntologyBiologicalProcess | box C/D sno(s)RNA metabolic process | 6.99e-06 | 3 | 32 | 2 | GO:0033967 | |
| GeneOntologyBiologicalProcess | box C/D sno(s)RNA processing | 6.99e-06 | 3 | 32 | 2 | GO:0034963 | |
| GeneOntologyBiologicalProcess | box C/D sno(s)RNA 3'-end processing | 6.99e-06 | 3 | 32 | 2 | GO:0000494 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 7.03e-06 | 309 | 32 | 6 | GO:0061013 | |
| GeneOntologyBiologicalProcess | RNA methylation | 7.66e-06 | 82 | 32 | 4 | GO:0001510 | |
| GeneOntologyBiologicalProcess | nuclear export | 9.10e-06 | 185 | 32 | 5 | GO:0051168 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.02e-05 | 88 | 32 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.43e-05 | 96 | 32 | 4 | GO:0006405 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.57e-05 | 207 | 32 | 5 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 2.05e-05 | 373 | 32 | 6 | GO:0006402 | |
| GeneOntologyBiologicalProcess | rRNA modification | 2.34e-05 | 36 | 32 | 3 | GO:0000154 | |
| GeneOntologyBiologicalProcess | methylation | 2.82e-05 | 234 | 32 | 5 | GO:0032259 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 4.58e-05 | 259 | 32 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 4.66e-05 | 432 | 32 | 6 | GO:0006401 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 6.92e-05 | 464 | 32 | 6 | GO:0141188 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 8.09e-05 | 292 | 32 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 8.46e-05 | 151 | 32 | 4 | GO:0045727 | |
| GeneOntologyBiologicalProcess | regulation of translation | 9.77e-05 | 494 | 32 | 6 | GO:0006417 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.04e-04 | 59 | 32 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.04e-04 | 308 | 32 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.50e-04 | 175 | 32 | 4 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.50e-04 | 175 | 32 | 4 | GO:0050657 | |
| GeneOntologyBiologicalProcess | sno(s)RNA 3'-end processing | 1.52e-04 | 12 | 32 | 2 | GO:0031126 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.60e-04 | 178 | 32 | 4 | GO:0051236 | |
| GeneOntologyBiologicalProcess | sno(s)RNA processing | 2.10e-04 | 14 | 32 | 2 | GO:0043144 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 2.94e-04 | 1153 | 32 | 8 | GO:0010608 | |
| GeneOntologyBiologicalProcess | intracellular transport | RBM15B SNX27 PPP1R10 TARDBP ALYREF SFPQ KHDRBS1 ATXN1 HNRNPA1 | 3.30e-04 | 1496 | 32 | 9 | GO:0046907 |
| GeneOntologyBiologicalProcess | sno(s)RNA metabolic process | 3.92e-04 | 19 | 32 | 2 | GO:0016074 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 4.28e-04 | 418 | 32 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 5.72e-04 | 249 | 32 | 4 | GO:0015931 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 6.18e-04 | 696 | 32 | 6 | GO:0034655 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome organization | 7.07e-04 | 113 | 32 | 3 | GO:2001252 | |
| GeneOntologyBiologicalProcess | mRNA modification | 7.40e-04 | 26 | 32 | 2 | GO:0016556 | |
| GeneOntologyBiologicalProcess | rRNA methylation | 7.99e-04 | 27 | 32 | 2 | GO:0031167 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.05e-03 | 31 | 32 | 2 | GO:0070935 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.45e-03 | 145 | 32 | 3 | GO:0051028 | |
| GeneOntologyBiologicalProcess | translation | 1.48e-03 | 824 | 32 | 6 | GO:0006412 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 2.12e-03 | 44 | 32 | 2 | GO:0048026 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 2.21e-03 | 168 | 32 | 3 | GO:0000723 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 2.62e-03 | 49 | 32 | 2 | GO:0050685 | |
| GeneOntologyBiologicalProcess | response to cold | 2.95e-03 | 52 | 32 | 2 | GO:0009409 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 3.09e-03 | 189 | 32 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | telomere organization | 3.57e-03 | 199 | 32 | 3 | GO:0032200 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.67e-03 | 201 | 32 | 3 | GO:0051170 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 3.93e-03 | 206 | 32 | 3 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 4.21e-03 | 211 | 32 | 3 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 4.21e-03 | 211 | 32 | 3 | GO:0061014 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 4.29e-03 | 63 | 32 | 2 | GO:0033120 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 4.88e-03 | 1399 | 32 | 7 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 5.05e-03 | 1053 | 32 | 6 | GO:0000122 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 5.15e-03 | 1413 | 32 | 7 | GO:1902679 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 5.31e-03 | 741 | 32 | 5 | GO:0006338 | |
| GeneOntologyBiologicalProcess | rRNA processing | 5.35e-03 | 230 | 32 | 3 | GO:0006364 | |
| GeneOntologyBiologicalProcess | positive regulation of telomere maintenance | 5.57e-03 | 72 | 32 | 2 | GO:0032206 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 5.87e-03 | 74 | 32 | 2 | GO:0006406 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 6.03e-03 | 75 | 32 | 2 | GO:0045109 | |
| GeneOntologyBiologicalProcess | telomere maintenance via telomerase | 6.35e-03 | 77 | 32 | 2 | GO:0007004 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleocytoplasmic transport | 6.67e-03 | 79 | 32 | 2 | GO:0046824 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | CIRBP HNRNPA0 ALYREF FBLL1 HNRNPUL1 GAR1 HNRNPA1 HNRNPA1L3 FBL HNRNPAB RBM3 | 8.55e-07 | 1194 | 32 | 11 | GO:1990904 |
| GeneOntologyCellularComponent | sno(s)RNA-containing ribonucleoprotein complex | 1.57e-05 | 32 | 32 | 3 | GO:0005732 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.76e-05 | 215 | 32 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | box C/D RNP complex | 4.74e-05 | 7 | 32 | 2 | GO:0170049 | |
| GeneOntologyCellularComponent | dense fibrillar component | 4.74e-05 | 7 | 32 | 2 | GO:0001651 | |
| GeneOntologyCellularComponent | box C/D methylation guide snoRNP complex | 4.74e-05 | 7 | 32 | 2 | GO:0031428 | |
| GeneOntologyCellularComponent | nuclear body | 4.90e-05 | 903 | 32 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 8.12e-05 | 9 | 32 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 1.45e-04 | 176 | 32 | 4 | GO:0000781 | |
| GeneOntologyCellularComponent | Cajal body | 2.85e-04 | 84 | 32 | 3 | GO:0015030 | |
| GeneOntologyCellularComponent | chromosomal region | 4.16e-04 | 421 | 32 | 5 | GO:0098687 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 4.36e-04 | 97 | 32 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 8.79e-04 | 1377 | 32 | 8 | GO:0140513 | |
| GeneOntologyCellularComponent | fibrillar center | 1.73e-03 | 156 | 32 | 3 | GO:0001650 | |
| GeneOntologyCellularComponent | nuclear speck | 4.06e-03 | 431 | 32 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | cornified envelope | 5.00e-03 | 69 | 32 | 2 | GO:0001533 | |
| GeneOntologyCellularComponent | small-subunit processome | 6.03e-03 | 76 | 32 | 2 | GO:0032040 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 7.93e-03 | 269 | 32 | 3 | GO:0036464 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 9.46e-03 | 96 | 32 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 9.47e-03 | 287 | 32 | 3 | GO:0035770 | |
| GeneOntologyCellularComponent | keratin filament | 9.65e-03 | 97 | 32 | 2 | GO:0045095 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.19e-02 | 108 | 32 | 2 | GO:0034708 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.23e-02 | 110 | 32 | 2 | GO:0120111 | |
| GeneOntologyCellularComponent | preribosome | 1.31e-02 | 114 | 32 | 2 | GO:0030684 | |
| Domain | RRM_1 | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 5.85e-13 | 208 | 30 | 10 | PF00076 |
| Domain | RRM | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 8.93e-13 | 217 | 30 | 10 | SM00360 |
| Domain | RRM_dom | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 1.40e-12 | 227 | 30 | 10 | IPR000504 |
| Domain | RRM | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 1.60e-12 | 230 | 30 | 10 | PS50102 |
| Domain | - | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 2.88e-12 | 244 | 30 | 10 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 5.01e-12 | 258 | 30 | 10 | IPR012677 |
| Domain | Keratin_2_head | 6.73e-04 | 24 | 30 | 2 | IPR032444 | |
| Domain | Keratin_2_head | 6.73e-04 | 24 | 30 | 2 | PF16208 | |
| Domain | Keratin_II | 7.91e-04 | 26 | 30 | 2 | IPR003054 | |
| Domain | Intermediate_filament_CS | 4.58e-03 | 63 | 30 | 2 | IPR018039 | |
| Domain | Filament | 5.79e-03 | 71 | 30 | 2 | SM01391 | |
| Domain | IF | 5.95e-03 | 72 | 30 | 2 | PS00226 | |
| Domain | Filament | 6.11e-03 | 73 | 30 | 2 | PF00038 | |
| Domain | IF | 6.60e-03 | 76 | 30 | 2 | IPR001664 | |
| Domain | - | 1.58e-02 | 120 | 30 | 2 | 3.40.50.150 | |
| Domain | SAM-dependent_MTases | 1.63e-02 | 122 | 30 | 2 | IPR029063 | |
| Pathway | WP_MRNA_PROCESSING | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H ATXN1 HNRNPA1 FBL HNRNPAB RBM3 | 3.55e-12 | 451 | 25 | 12 | MM15946 |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 3.01e-05 | 5 | 25 | 2 | M27731 | |
| Pathway | REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING | 3.01e-05 | 5 | 25 | 2 | MM15481 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.37e-03 | 724 | 25 | 6 | M16843 | |
| Pathway | WP_MRNA_PROCESSING | 1.39e-03 | 126 | 25 | 3 | M39406 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CIRBP RBM15B HNRNPA0 PPP1R10 TARDBP ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 EIF4H HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 1.10e-21 | 807 | 32 | 18 | 22681889 |
| Pubmed | CIRBP RBM15B HNRNPA0 ALYREF FAM98A SFPQ IRS4 CKAP4 FBLL1 HNRNPUL1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 5.43e-19 | 731 | 32 | 16 | 29298432 | |
| Pubmed | CIRBP RBM15B HNRNPA0 TARDBP ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 1.68e-17 | 713 | 32 | 15 | 29802200 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBM15B HNRNPA0 PPP1R10 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 PRRC2A HNRNPAB RBM3 | 3.62e-17 | 954 | 32 | 16 | 36373674 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | CIRBP HNRNPA0 TARDBP KRT5 ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB RBM3 | 3.70e-17 | 430 | 32 | 13 | 38172120 |
| Pubmed | CIRBP HNRNPA0 PPP1R10 TARDBP KRT5 ALYREF FAM98A SFPQ IRS4 CKAP4 KHDRBS1 GAR1 FBL PRRC2A HNRNPAB RBM3 | 4.77e-17 | 971 | 32 | 16 | 33306668 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPA0 PPP1R10 TARDBP KRT5 ALYREF SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 EIF4H HNRNPA1 FBL HNRNPAB KRT77 | 1.10e-16 | 1024 | 32 | 16 | 24711643 |
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 5.53e-16 | 30 | 32 | 7 | 15782174 | |
| Pubmed | CIRBP HNRNPA0 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB RBM3 | 8.62e-16 | 725 | 32 | 14 | 27025967 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RBM15B HNRNPA0 PPP1R10 TARDBP KRT5 ALYREF SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB KRT77 METTL14 | 2.69e-15 | 1257 | 32 | 16 | 36526897 |
| Pubmed | CIRBP HNRNPA0 PPP1R10 TARDBP ALYREF CNOT11 SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 HNRNPAB | 3.89e-15 | 809 | 32 | 14 | 32129710 | |
| Pubmed | HNRNPA0 ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 HNRNPAB | 3.96e-15 | 216 | 32 | 10 | 37640791 | |
| Pubmed | CIRBP ZBTB10 HNRNPA0 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB | 6.85e-15 | 1335 | 32 | 16 | 29229926 | |
| Pubmed | CIRBP RBM15B ZBTB10 HNRNPA0 TARDBP FAM98A SFPQ CKAP4 FBLL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 7.29e-15 | 847 | 32 | 14 | 35850772 | |
| Pubmed | 1.25e-14 | 153 | 32 | 9 | 28225217 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | HNRNPA0 TARDBP ALYREF CNOT11 FAM98A IRS4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 1.30e-14 | 678 | 32 | 13 | 30209976 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | CIRBP HNRNPA0 TARDBP ALYREF SFPQ CKAP4 EIF4H HNRNPA1 PRRC2A HNRNPAB | 2.37e-14 | 258 | 32 | 10 | 37794589 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | CIRBP HNRNPA0 PPP1R10 TARDBP ALYREF SFPQ FBLL1 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 | 6.05e-14 | 989 | 32 | 14 | 36424410 |
| Pubmed | HNRNPA0 TARDBP KRT5 ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB | 7.37e-14 | 421 | 32 | 11 | 34650049 | |
| Pubmed | HNRNPA0 PPP1R10 ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A | 1.37e-13 | 615 | 32 | 12 | 31048545 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CIRBP RBM15B HNRNPA0 PPP1R10 TARDBP KRT5 SFPQ CKAP4 FBLL1 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 HNRNPAB | 2.05e-13 | 1082 | 32 | 14 | 38697112 |
| Pubmed | HNRNPA0 TARDBP ALYREF SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 | 2.73e-13 | 652 | 32 | 12 | 31180492 | |
| Pubmed | HNRNPA0 PPP1R10 TARDBP SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 3.72e-13 | 340 | 32 | 10 | 24332808 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CIRBP HNRNPA0 KRT5 ALYREF CNOT11 FAM98A SFPQ CKAP4 HNRNPUL1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 3.80e-13 | 1415 | 32 | 15 | 28515276 |
| Pubmed | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ KHDRBS1 HNRNPA1 HNRNPAB RBM3 | 4.56e-13 | 347 | 32 | 10 | 16033648 | |
| Pubmed | CIRBP HNRNPA0 KRT5 ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 KRT77 | 4.84e-13 | 1153 | 32 | 14 | 29845934 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | HNRNPA0 SNX27 KRT5 ALYREF FAM98A SFPQ IRS4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB | 6.41e-13 | 922 | 32 | 13 | 27609421 |
| Pubmed | CIRBP HNRNPA0 TARDBP KRT5 ALYREF SFPQ GAR1 EIF4H HNRNPA1 FBL HNRNPAB RBM3 | 7.07e-13 | 707 | 32 | 12 | 19738201 | |
| Pubmed | HNRNPA0 PPP1R10 TARDBP SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 8.65e-13 | 244 | 32 | 9 | 29884807 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | CIRBP HNRNPA0 ALYREF FAM98A CKAP4 HNRNPUL1 GAR1 HNRNPA1 PRRC2A HNRNPAB | 1.25e-12 | 384 | 32 | 10 | 31059266 |
| Pubmed | TARDBP ALYREF FAM98A SFPQ IRS4 HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB KRT77 | 1.37e-12 | 551 | 32 | 11 | 34728620 | |
| Pubmed | HNRNPA0 ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB | 1.53e-12 | 260 | 32 | 9 | 36199071 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RBM15B HNRNPA0 PPP1R10 TARDBP ALYREF SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 | 2.29e-12 | 1294 | 32 | 14 | 30804502 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | HNRNPA0 TARDBP ALYREF SFPQ IRS4 FBLL1 KHDRBS1 HNRNPA1 HNRNPAB RBM3 | 2.44e-12 | 411 | 32 | 10 | 35182466 |
| Pubmed | HNRNPA0 TARDBP SFPQ IRS4 HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 2.45e-12 | 274 | 32 | 9 | 34244482 | |
| Pubmed | 2.89e-12 | 172 | 32 | 8 | 26336360 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RBM15B HNRNPA0 KRT5 ALYREF FAM98A SFPQ KHDRBS1 HNRNPA1 FBL HNRNPAB KRT77 | 3.74e-12 | 605 | 32 | 11 | 28977666 |
| Pubmed | 7.71e-12 | 109 | 32 | 7 | 29511296 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | HNRNPA0 TARDBP ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 7.72e-12 | 462 | 32 | 10 | 31138677 |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | HNRNPA0 ALYREF CKAP4 HNRNPUL1 KHDRBS1 EIF4H FBL PRRC2A HNRNPAB | 1.26e-11 | 329 | 32 | 9 | 34316702 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | RBM15B HNRNPA0 TARDBP ALYREF CNOT11 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 1.81e-11 | 701 | 32 | 11 | 30196744 |
| Pubmed | CIRBP HNRNPA0 TARDBP ALYREF SFPQ CKAP4 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 2.11e-11 | 711 | 32 | 11 | 33022573 | |
| Pubmed | 2.32e-11 | 223 | 32 | 8 | 20020773 | ||
| Pubmed | CIRBP HNRNPA0 TARDBP FAM98A SFPQ GAR1 EIF4H HNRNPA1 FBL RBM3 METTL14 | 2.52e-11 | 723 | 32 | 11 | 34133714 | |
| Pubmed | 3.71e-11 | 136 | 32 | 7 | 26979993 | ||
| Pubmed | 4.03e-11 | 239 | 32 | 8 | 26641092 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 6.43e-11 | 147 | 32 | 7 | 28977470 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ZBTB10 HNRNPA0 SNX27 TARDBP ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 EIF4H HNRNPA1 FBL HNRNPAB | 7.69e-11 | 1353 | 32 | 13 | 29467282 |
| Pubmed | 9.77e-11 | 156 | 32 | 7 | 26170170 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | HNRNPA0 TARDBP KRT5 ALYREF SFPQ IRS4 KHDRBS1 HNRNPA1 FBL HNRNPAB | 1.06e-10 | 604 | 32 | 10 | 37616343 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RBM15B HNRNPA0 TARDBP ALYREF SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB | 1.46e-10 | 1425 | 32 | 13 | 30948266 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TARDBP KRT5 FAM98A SFPQ HNRNPUL1 KHDRBS1 GAR1 EIF4H HNRNPA1 FBL | 1.50e-10 | 626 | 32 | 10 | 33644029 |
| Pubmed | 1.69e-10 | 441 | 32 | 9 | 31239290 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CIRBP TARDBP KRT5 ALYREF SFPQ IRS4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB | 1.96e-10 | 1149 | 32 | 12 | 35446349 |
| Pubmed | 2.18e-10 | 90 | 32 | 6 | 23151878 | ||
| Pubmed | HNRNPA0 SFPQ CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 2.91e-10 | 469 | 32 | 9 | 37314180 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | HNRNPA0 ALYREF IRS4 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB | 3.57e-10 | 480 | 32 | 9 | 25437307 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 3.61e-10 | 315 | 32 | 8 | 26777405 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | HNRNPA0 ALYREF FAM98A IRS4 CKAP4 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 3.98e-10 | 486 | 32 | 9 | 30940648 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HNRNPA0 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 5.36e-10 | 714 | 32 | 10 | 28302793 |
| Pubmed | 5.59e-10 | 333 | 32 | 8 | 36779763 | ||
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 1.20e-09 | 52 | 32 | 5 | 24591637 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | TARDBP KRT5 ALYREF SFPQ HNRNPUL1 HNRNPA1 PRRC2A HNRNPAB KRT77 | 1.33e-09 | 558 | 32 | 9 | 27591049 |
| Pubmed | CIRBP RBM15B PPP1R10 TARDBP ALYREF FAM98A CKAP4 GAR1 FBL PRRC2A RBM3 KRT77 | 1.46e-09 | 1371 | 32 | 12 | 36244648 | |
| Pubmed | CIRBP TARDBP KRT5 ALYREF SFPQ CKAP4 HNRNPA1 FBL HNRNPAB KRT77 | 1.66e-09 | 803 | 32 | 10 | 36517590 | |
| Pubmed | FGF11 induced by hypoxia interacts with HIF-1α and enhances its stability. | 1.85e-09 | 128 | 32 | 6 | 28027390 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | HNRNPA0 KRT5 FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPAB KRT77 | 1.87e-09 | 580 | 32 | 9 | 35676659 |
| Pubmed | 1.94e-09 | 390 | 32 | 8 | 17643375 | ||
| Pubmed | 2.04e-09 | 241 | 32 | 7 | 23125841 | ||
| Pubmed | 2.13e-09 | 131 | 32 | 6 | 34551306 | ||
| Pubmed | CIRBP HNRNPA0 ALYREF SFPQ HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB RBM3 | 2.18e-09 | 1103 | 32 | 11 | 34189442 | |
| Pubmed | TARDBP KRT5 FAM98A SFPQ CKAP4 HNRNPUL1 HNRNPA1 FBL HNRNPAB RBM3 | 2.67e-09 | 844 | 32 | 10 | 25963833 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HNRNPA0 PPP1R10 TARDBP ALYREF CNOT11 SFPQ HNRNPUL1 GAR1 EIF4H FBL HNRNPAB | 3.51e-09 | 1155 | 32 | 11 | 20360068 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 3.53e-09 | 624 | 32 | 9 | 33729478 | |
| Pubmed | 3.77e-09 | 65 | 32 | 5 | 32521226 | ||
| Pubmed | 4.46e-09 | 641 | 32 | 9 | 36057605 | ||
| Pubmed | 6.67e-09 | 286 | 32 | 7 | 32041737 | ||
| Pubmed | 7.32e-09 | 74 | 32 | 5 | 33989516 | ||
| Pubmed | 7.38e-09 | 463 | 32 | 8 | 34901782 | ||
| Pubmed | 1.16e-08 | 491 | 32 | 8 | 22623428 | ||
| Pubmed | 1.17e-08 | 174 | 32 | 6 | 35031058 | ||
| Pubmed | TERRA transcripts are bound by a complex array of RNA-binding proteins. | 1.19e-08 | 28 | 32 | 4 | 20975687 | |
| Pubmed | 1.57e-08 | 86 | 32 | 5 | 26885983 | ||
| Pubmed | 1.80e-08 | 187 | 32 | 6 | 29777862 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.92e-08 | 759 | 32 | 9 | 35915203 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 2.45e-08 | 197 | 32 | 6 | 22365833 | |
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 2.67e-08 | 350 | 32 | 7 | 26549023 | |
| Pubmed | 2.85e-08 | 202 | 32 | 6 | 24639526 | ||
| Pubmed | 2.88e-08 | 552 | 32 | 8 | 36293380 | ||
| Pubmed | 3.11e-08 | 205 | 32 | 6 | 27976729 | ||
| Pubmed | HNRNPA0 TARDBP KRT5 FAM98A SFPQ IRS4 KHDRBS1 GAR1 HNRNPA1 HNRNPAB KRT77 | 3.46e-08 | 1442 | 32 | 11 | 35575683 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 4.36e-08 | 217 | 32 | 6 | 31685992 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.39e-08 | 583 | 32 | 8 | 29844126 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.73e-08 | 220 | 32 | 6 | 35785414 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | KRT5 ALYREF SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB KRT77 | 5.03e-08 | 1496 | 32 | 11 | 32877691 |
| Pubmed | 5.54e-08 | 601 | 32 | 8 | 33658012 | ||
| Pubmed | 6.52e-08 | 399 | 32 | 7 | 35987950 | ||
| Pubmed | 7.16e-08 | 236 | 32 | 6 | 36339263 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 7.53e-08 | 238 | 32 | 6 | 35864588 | |
| Pubmed | 8.76e-08 | 638 | 32 | 8 | 33239621 | ||
| Interaction | ZC3H18 interactions | CIRBP RBM15B HNRNPA0 ALYREF FAM98A SFPQ IRS4 CKAP4 FBLL1 HNRNPUL1 GAR1 ATXN1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 4.35e-16 | 877 | 30 | 17 | int:ZC3H18 |
| Interaction | PRMT1 interactions | CIRBP TARDBP ALYREF FAM98A SFPQ IRS4 HNRNPUL1 KHDRBS1 GAR1 ATXN1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 KRT77 METTL14 | 1.13e-15 | 929 | 30 | 17 | int:PRMT1 |
| Interaction | MYCN interactions | CIRBP RBM15B HNRNPA0 TARDBP KRT5 ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 KRT77 | 1.60e-15 | 1373 | 30 | 19 | int:MYCN |
| Interaction | SNRNP70 interactions | CIRBP RBM15B HNRNPA0 TARDBP ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 GAR1 ATXN1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 METTL14 | 2.93e-15 | 984 | 30 | 17 | int:SNRNP70 |
| Interaction | FUS interactions | HNRNPA0 SNX27 PPP1R10 TARDBP ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB METTL14 | 3.35e-14 | 757 | 30 | 15 | int:FUS |
| Interaction | FZR1 interactions | CIRBP HNRNPA0 PPP1R10 TARDBP KRT5 ALYREF FAM98A SFPQ IRS4 CKAP4 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 5.18e-14 | 1172 | 30 | 17 | int:FZR1 |
| Interaction | SMC5 interactions | RBM15B HNRNPA0 PPP1R10 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 PRRC2A HNRNPAB RBM3 | 9.07e-14 | 1000 | 30 | 16 | int:SMC5 |
| Interaction | CUL7 interactions | RBM15B HNRNPA0 TARDBP KRT5 ALYREF SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 EIF4H HNRNPA1 FBL PRRC2A HNRNPAB | 1.66e-13 | 845 | 30 | 15 | int:CUL7 |
| Interaction | RC3H1 interactions | CIRBP HNRNPA0 KRT5 ALYREF CNOT11 FAM98A SFPQ IRS4 HNRNPUL1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 1.81e-13 | 677 | 30 | 14 | int:RC3H1 |
| Interaction | SYNCRIP interactions | HNRNPA0 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 GAR1 EIF4H ATXN1 HNRNPA1 FBL PRRC2A HNRNPAB METTL14 | 4.25e-13 | 721 | 30 | 14 | int:SYNCRIP |
| Interaction | PHB1 interactions | CIRBP HNRNPA0 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 ATXN1 HNRNPA1 PRRC2A HNRNPAB RBM3 METTL14 | 5.40e-13 | 1123 | 30 | 16 | int:PHB1 |
| Interaction | UFL1 interactions | CIRBP HNRNPA0 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB METTL14 | 2.93e-12 | 1031 | 30 | 15 | int:UFL1 |
| Interaction | RC3H2 interactions | HNRNPA0 TARDBP ALYREF CNOT11 FAM98A IRS4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 3.63e-12 | 667 | 30 | 13 | int:RC3H2 |
| Interaction | MEPCE interactions | CIRBP RBM15B HNRNPA0 PPP1R10 KRT5 ALYREF SFPQ CKAP4 HNRNPUL1 HNRNPA1 FBL HNRNPAB RBM3 KRT77 | 4.53e-12 | 859 | 30 | 14 | int:MEPCE |
| Interaction | CAND1 interactions | CIRBP HNRNPA0 TARDBP KRT5 ALYREF FAM98A HNRNPUL1 KHDRBS1 GAR1 ATXN1 HNRNPA1 PRRC2A HNRNPAB RBM3 | 7.75e-12 | 894 | 30 | 14 | int:CAND1 |
| Interaction | ACE2 interactions | HNRNPA0 SNX27 TARDBP KRT5 ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 FBL HNRNPAB | 8.01e-12 | 1106 | 30 | 15 | int:ACE2 |
| Interaction | LARP7 interactions | CIRBP HNRNPA0 KRT5 ALYREF SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 KRT77 | 8.76e-12 | 1113 | 30 | 15 | int:LARP7 |
| Interaction | CUL4B interactions | CIRBP HNRNPA0 KRT5 ALYREF SFPQ IRS4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 | 1.09e-11 | 728 | 30 | 13 | int:CUL4B |
| Interaction | HNRNPA1 interactions | CIRBP RBM15B HNRNPA0 TARDBP KRT5 ALYREF SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB RBM3 METTL14 | 1.63e-11 | 945 | 30 | 14 | int:HNRNPA1 |
| Interaction | RECQL4 interactions | CIRBP ZBTB10 HNRNPA0 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB | 1.76e-11 | 1412 | 30 | 16 | int:RECQL4 |
| Interaction | CUL2 interactions | CIRBP HNRNPA0 TARDBP KRT5 ALYREF FAM98A IRS4 HNRNPUL1 HNRNPA1 HNRNPAB RBM3 METTL14 | 1.93e-11 | 591 | 30 | 12 | int:CUL2 |
| Interaction | TRIM31 interactions | HNRNPA0 TARDBP KRT5 ALYREF FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB | 2.50e-11 | 454 | 30 | 11 | int:TRIM31 |
| Interaction | EFTUD2 interactions | CIRBP HNRNPA0 KRT5 ALYREF CNOT11 FAM98A SFPQ CKAP4 HNRNPUL1 GAR1 ATXN1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 2.61e-11 | 1449 | 30 | 16 | int:EFTUD2 |
| Interaction | CIT interactions | HNRNPA0 SNX27 TARDBP ALYREF FAM98A SFPQ CKAP4 FBLL1 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB RBM3 | 2.63e-11 | 1450 | 30 | 16 | int:CIT |
| Interaction | RBMX interactions | CIRBP HNRNPA0 TARDBP SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB RBM3 METTL14 | 2.94e-11 | 461 | 30 | 11 | int:RBMX |
| Interaction | DOT1L interactions | CIRBP RBM15B HNRNPA0 TARDBP ALYREF FAM98A SFPQ CKAP4 FBLL1 HNRNPA1 FBL PRRC2A HNRNPAB | 3.94e-11 | 807 | 30 | 13 | int:DOT1L |
| Interaction | DDRGK1 interactions | CIRBP HNRNPA0 TARDBP ALYREF FAM98A SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB RBM3 | 4.52e-11 | 1249 | 30 | 15 | int:DDRGK1 |
| Interaction | G3BP1 interactions | CIRBP ZBTB10 PPP1R10 TARDBP FAM98A IRS4 HNRNPUL1 EIF4H HNRNPA1 FBL PRRC2A HNRNPAB METTL14 | 6.02e-11 | 835 | 30 | 13 | int:G3BP1 |
| Interaction | MATR3 interactions | RBM15B HNRNPA0 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 ATXN1 HNRNPA1 FBL RBM3 METTL14 | 6.36e-11 | 655 | 30 | 12 | int:MATR3 |
| Interaction | KIF20A interactions | HNRNPA0 TARDBP ALYREF FAM98A SFPQ CKAP4 FBLL1 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A HNRNPAB | 6.80e-11 | 1052 | 30 | 14 | int:KIF20A |
| Interaction | MECP2 interactions | CIRBP RBM15B HNRNPA0 PPP1R10 TARDBP KRT5 SFPQ CKAP4 FBLL1 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB | 6.90e-11 | 1287 | 30 | 15 | int:MECP2 |
| Interaction | FN1 interactions | CIRBP HNRNPA0 TARDBP KRT5 ALYREF SFPQ GAR1 EIF4H HNRNPA1 FBL HNRNPAB RBM3 METTL14 | 7.30e-11 | 848 | 30 | 13 | int:FN1 |
| Interaction | COPS5 interactions | CIRBP HNRNPA0 KRT5 ALYREF FAM98A SFPQ IRS4 CKAP4 FBLL1 HNRNPUL1 HNRNPA1 FBL HNRNPAB RBM3 | 1.26e-10 | 1102 | 30 | 14 | int:COPS5 |
| Interaction | OBSL1 interactions | CIRBP HNRNPA0 PPP1R10 KRT5 ALYREF SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB | 1.57e-10 | 902 | 30 | 13 | int:OBSL1 |
| Interaction | GATA4 interactions | HNRNPA0 TARDBP ALYREF SFPQ IRS4 FBLL1 KHDRBS1 HNRNPA1 HNRNPAB RBM3 | 2.33e-10 | 411 | 30 | 10 | int:GATA4 |
| Interaction | SFPQ interactions | PPP1R10 TARDBP ALYREF FAM98A SFPQ KHDRBS1 ATXN1 HNRNPA1 PRRC2A HNRNPAB METTL14 | 2.48e-10 | 563 | 30 | 11 | int:SFPQ |
| Interaction | FUBP3 interactions | ZBTB10 TARDBP CNOT11 FAM98A HNRNPUL1 ATXN1 HNRNPA1 FBL PRRC2A | 3.17e-10 | 297 | 30 | 9 | int:FUBP3 |
| Interaction | GLDC interactions | HNRNPA0 TARDBP SFPQ IRS4 HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 6.29e-10 | 321 | 30 | 9 | int:GLDC |
| Interaction | NFX1 interactions | CIRBP HNRNPA0 ALYREF FAM98A CKAP4 HNRNPUL1 GAR1 HNRNPA1 PRRC2A HNRNPAB | 7.88e-10 | 466 | 30 | 10 | int:NFX1 |
| Interaction | SNRPA interactions | CIRBP HNRNPA0 PPP1R10 ALYREF SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPAB RBM3 | 1.09e-09 | 482 | 30 | 10 | int:SNRPA |
| Interaction | WWP2 interactions | HNRNPA0 PPP1R10 ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL PRRC2A | 1.10e-09 | 840 | 30 | 12 | int:WWP2 |
| Interaction | U2AF2 interactions | HNRNPA0 TARDBP ALYREF SFPQ KHDRBS1 EIF4H ATXN1 HNRNPA1 FBL HNRNPAB METTL14 | 1.15e-09 | 651 | 30 | 11 | int:U2AF2 |
| Interaction | BMI1 interactions | CIRBP HNRNPA0 TARDBP ALYREF CKAP4 HNRNPUL1 KHDRBS1 EIF4H FBL PRRC2A HNRNPAB | 1.30e-09 | 659 | 30 | 11 | int:BMI1 |
| Interaction | HNRNPK interactions | CIRBP HNRNPA0 PPP1R10 TARDBP ALYREF SFPQ KHDRBS1 GAR1 HNRNPA1 HNRNPAB RBM3 METTL14 | 1.31e-09 | 853 | 30 | 12 | int:HNRNPK |
| Interaction | HNRNPA0 interactions | CIRBP HNRNPA0 TARDBP HNRNPUL1 EIF4H ATXN1 HNRNPA1 HNRNPAB RBM3 | 1.31e-09 | 349 | 30 | 9 | int:HNRNPA0 |
| Interaction | PSPC1 interactions | ZBTB10 HNRNPA0 PPP1R10 ALYREF FAM98A SFPQ CKAP4 EIF4H HNRNPA1 PRRC2A | 2.07e-09 | 515 | 30 | 10 | int:PSPC1 |
| Interaction | G3BP2 interactions | ZBTB10 PPP1R10 TARDBP CNOT11 IRS4 CKAP4 HNRNPUL1 HNRNPA1 PRRC2A METTL14 | 2.19e-09 | 518 | 30 | 10 | int:G3BP2 |
| Interaction | TARDBP interactions | HNRNPA0 TARDBP FAM98A SFPQ HNRNPUL1 HNRNPA1 FBL PRRC2A HNRNPAB METTL14 | 2.27e-09 | 520 | 30 | 10 | int:TARDBP |
| Interaction | HEXIM1 interactions | CIRBP HNRNPA0 PPP1R10 KRT5 ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 HNRNPA1 HNRNPAB KRT77 | 2.83e-09 | 913 | 30 | 12 | int:HEXIM1 |
| Interaction | PTEN interactions | CIRBP SNX27 PPP1R10 ALYREF IRS4 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 3.44e-09 | 929 | 30 | 12 | int:PTEN |
| Interaction | METTL14 interactions | TARDBP KRT5 ALYREF SFPQ HNRNPUL1 HNRNPA1 FBL HNRNPAB KRT77 METTL14 | 4.46e-09 | 558 | 30 | 10 | int:METTL14 |
| Interaction | TNIP2 interactions | HNRNPA0 KRT5 ALYREF FAM98A SFPQ IRS4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB | 4.53e-09 | 952 | 30 | 12 | int:TNIP2 |
| Interaction | SF3A2 interactions | 4.63e-09 | 273 | 30 | 8 | int:SF3A2 | |
| Interaction | DDX5 interactions | HNRNPA0 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB METTL14 | 5.29e-09 | 568 | 30 | 10 | int:DDX5 |
| Interaction | CELF1 interactions | 7.03e-09 | 288 | 30 | 8 | int:CELF1 | |
| Interaction | BTRC interactions | HNRNPA0 ALYREF CNOT11 FAM98A SFPQ HNRNPUL1 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 7.09e-09 | 775 | 30 | 11 | int:BTRC |
| Interaction | STIP1 interactions | HNRNPA0 TARDBP SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 ATXN1 HNRNPA1 FBL HNRNPAB METTL14 | 8.42e-09 | 1006 | 30 | 12 | int:STIP1 |
| Interaction | PRMT8 interactions | 8.77e-09 | 104 | 30 | 6 | int:PRMT8 | |
| Interaction | RBM39 interactions | HNRNPA0 PPP1R10 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 ATXN1 HNRNPA1 FBL PRRC2A HNRNPAB | 1.25e-08 | 1042 | 30 | 12 | int:RBM39 |
| Interaction | ATXN2 interactions | 1.31e-08 | 312 | 30 | 8 | int:ATXN2 | |
| Interaction | MIDN interactions | HNRNPA0 TARDBP KRT5 ALYREF SFPQ IRS4 KHDRBS1 HNRNPA1 FBL HNRNPAB | 1.33e-08 | 626 | 30 | 10 | int:MIDN |
| Interaction | BRD7 interactions | HNRNPA0 ALYREF FAM98A IRS4 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 PRRC2A HNRNPAB | 1.57e-08 | 637 | 30 | 10 | int:BRD7 |
| Interaction | PRMT5 interactions | 1.78e-08 | 471 | 30 | 9 | int:PRMT5 | |
| Interaction | RBM45 interactions | 1.82e-08 | 207 | 30 | 7 | int:RBM45 | |
| Interaction | BIRC3 interactions | RBM15B HNRNPA0 TARDBP ALYREF SFPQ IRS4 CKAP4 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB | 1.83e-08 | 1334 | 30 | 13 | int:BIRC3 |
| Interaction | HDLBP interactions | CIRBP RBM15B PPP1R10 ALYREF CKAP4 GAR1 ATXN1 FBL PRRC2A RBM3 METTL14 | 1.96e-08 | 855 | 30 | 11 | int:HDLBP |
| Interaction | DHX9 interactions | HNRNPA0 TARDBP ALYREF SFPQ HNRNPUL1 KHDRBS1 ATXN1 HNRNPA1 HNRNPAB METTL14 | 2.27e-08 | 662 | 30 | 10 | int:DHX9 |
| Interaction | USP48 interactions | HNRNPA0 TARDBP SFPQ HNRNPUL1 KHDRBS1 GAR1 ATXN1 HNRNPA1 HNRNPAB KRT77 | 2.47e-08 | 668 | 30 | 10 | int:USP48 |
| Interaction | KHDRBS2 interactions | 3.20e-08 | 129 | 30 | 6 | int:KHDRBS2 | |
| Interaction | EWSR1 interactions | TARDBP ALYREF SFPQ CKAP4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB METTL14 | 3.55e-08 | 906 | 30 | 11 | int:EWSR1 |
| Interaction | WDR77 interactions | 4.07e-08 | 361 | 30 | 8 | int:WDR77 | |
| Interaction | SRSF3 interactions | 4.32e-08 | 522 | 30 | 9 | int:SRSF3 | |
| Interaction | CPSF6 interactions | HNRNPA0 PPP1R10 ALYREF SFPQ HNRNPUL1 KHDRBS1 ATXN1 HNRNPA1 METTL14 | 4.61e-08 | 526 | 30 | 9 | int:CPSF6 |
| Interaction | DDX21 interactions | HNRNPA0 TARDBP ALYREF SFPQ KHDRBS1 ATXN1 HNRNPA1 FBL HNRNPAB METTL14 | 4.87e-08 | 718 | 30 | 10 | int:DDX21 |
| Interaction | RPS16 interactions | HNRNPA0 TARDBP ALYREF FAM98A SFPQ CKAP4 HNRNPUL1 FBL PRRC2A METTL14 | 5.27e-08 | 724 | 30 | 10 | int:RPS16 |
| Interaction | HNRNPR interactions | HNRNPA0 TARDBP SFPQ KHDRBS1 HNRNPA1 FBL HNRNPAB RBM3 METTL14 | 5.41e-08 | 536 | 30 | 9 | int:HNRNPR |
| Interaction | IL7R interactions | 5.45e-08 | 141 | 30 | 6 | int:IL7R | |
| Interaction | ITFG1 interactions | HNRNPA0 ALYREF IRS4 CKAP4 HNRNPUL1 KHDRBS1 HNRNPA1 FBL HNRNPAB | 5.77e-08 | 540 | 30 | 9 | int:ITFG1 |
| Interaction | GRM2 interactions | 6.17e-08 | 381 | 30 | 8 | int:GRM2 | |
| Interaction | PRC1 interactions | HNRNPA0 TARDBP ALYREF SFPQ FBLL1 HNRNPUL1 KHDRBS1 GAR1 HNRNPA1 FBL HNRNPAB | 7.36e-08 | 973 | 30 | 11 | int:PRC1 |
| Interaction | DMRT2 interactions | 7.97e-08 | 28 | 30 | 4 | int:DMRT2 | |
| Interaction | CHD3 interactions | HNRNPA0 KRT5 ALYREF FAM98A SFPQ KHDRBS1 HNRNPA1 FBL HNRNPAB KRT77 | 8.00e-08 | 757 | 30 | 10 | int:CHD3 |
| Interaction | LSM14A interactions | 8.67e-08 | 260 | 30 | 7 | int:LSM14A | |
| Interaction | CUL5 interactions | CIRBP HNRNPA0 KRT5 FAM98A HNRNPUL1 HNRNPA1 HNRNPAB RBM3 KRT77 | 8.75e-08 | 567 | 30 | 9 | int:CUL5 |
| Interaction | YWHAE interactions | KCNK3 SNX27 TARDBP SFPQ IRS4 HNRNPUL1 ATXN1 HNRNPA1 PRRC2A HNRNPAB RBM3 KRT77 | 9.86e-08 | 1256 | 30 | 12 | int:YWHAE |
| Interaction | UPF1 interactions | 1.08e-07 | 581 | 30 | 9 | int:UPF1 | |
| Interaction | ILF2 interactions | TARDBP ALYREF SFPQ HNRNPUL1 ATXN1 HNRNPA1 HNRNPAB RBM3 METTL14 | 1.23e-07 | 590 | 30 | 9 | int:ILF2 |
| Interaction | DCUN1D1 interactions | 1.27e-07 | 275 | 30 | 7 | int:DCUN1D1 | |
| Interaction | MEN1 interactions | ZBTB10 PPP1R10 TARDBP FAM98A SFPQ CKAP4 FBLL1 KHDRBS1 FBL PRRC2A HNRNPAB | 1.30e-07 | 1029 | 30 | 11 | int:MEN1 |
| Interaction | BTF3 interactions | TARDBP KRT5 FAM98A SFPQ HNRNPUL1 KHDRBS1 GAR1 EIF4H HNRNPA1 FBL | 1.32e-07 | 799 | 30 | 10 | int:BTF3 |
| Interaction | DDX17 interactions | 1.45e-07 | 426 | 30 | 8 | int:DDX17 | |
| Interaction | ZC3HAV1 interactions | 1.54e-07 | 606 | 30 | 9 | int:ZC3HAV1 | |
| Interaction | BAP1 interactions | CIRBP TARDBP KRT5 ALYREF SFPQ IRS4 HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 PRRC2A HNRNPAB | 1.61e-07 | 1314 | 30 | 12 | int:BAP1 |
| Interaction | FGF11 interactions | 1.66e-07 | 170 | 30 | 6 | int:FGF11 | |
| Interaction | ZCCHC3 interactions | 1.71e-07 | 171 | 30 | 6 | int:ZCCHC3 | |
| Interaction | SNRPC interactions | HNRNPA0 PPP1R10 TARDBP ALYREF HNRNPUL1 KHDRBS1 HNRNPA1 HNRNPAB | 1.86e-07 | 440 | 30 | 8 | int:SNRPC |
| Interaction | MCM2 interactions | TARDBP KRT5 FAM98A SFPQ CKAP4 HNRNPUL1 ATXN1 HNRNPA1 FBL HNRNPAB RBM3 | 2.14e-07 | 1081 | 30 | 11 | int:MCM2 |
| Interaction | PPP1R10 interactions | 2.25e-07 | 179 | 30 | 6 | int:PPP1R10 | |
| Interaction | CAPRIN1 interactions | 2.25e-07 | 451 | 30 | 8 | int:CAPRIN1 | |
| Interaction | WDR5 interactions | CIRBP HNRNPA0 TARDBP ALYREF SFPQ CKAP4 KHDRBS1 HNRNPA1 FBL PRRC2A HNRNPAB | 2.57e-07 | 1101 | 30 | 11 | int:WDR5 |
| Cytoband | 12q13.13 | 1.01e-03 | 67 | 32 | 2 | 12q13.13 | |
| GeneFamily | RNA binding motif containing | CIRBP RBM15B HNRNPA0 TARDBP ALYREF SFPQ EIF4H HNRNPA1 HNRNPAB RBM3 | 4.17e-14 | 213 | 23 | 10 | 725 |
| GeneFamily | Keratins, type II | 5.33e-04 | 27 | 23 | 2 | 609 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.20e-02 | 181 | 23 | 2 | 694 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SNX27 TARDBP CNOT11 FAM98A SFPQ HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 FBL HNRNPAB | 3.45e-08 | 1129 | 31 | 11 | M42508 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | SNX27 TARDBP CNOT11 FAM98A SFPQ HNRNPUL1 KHDRBS1 EIF4H HNRNPA1 FBL HNRNPAB | 4.47e-08 | 1158 | 31 | 11 | MM1338 |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | 1.15e-07 | 200 | 31 | 6 | M5779 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 1.48e-07 | 352 | 31 | 7 | MM3788 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 2.48e-07 | 380 | 31 | 7 | M41703 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 3.17e-07 | 394 | 31 | 7 | MM3724 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 2.26e-06 | 79 | 31 | 4 | M40003 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP | 3.56e-06 | 200 | 31 | 5 | M5787 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 5.90e-06 | 612 | 31 | 7 | MM3804 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | 6.80e-06 | 891 | 31 | 8 | M41654 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | 1.05e-05 | 669 | 31 | 7 | M18635 | |
| Coexpression | MISSIAGLIA_REGULATED_BY_METHYLATION_DN | 1.28e-05 | 122 | 31 | 4 | M6866 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 2.74e-05 | 305 | 31 | 5 | M40025 | |
| Coexpression | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP | 2.83e-05 | 50 | 31 | 3 | M6562 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 4.13e-05 | 1144 | 31 | 8 | MM3843 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_DN | 4.51e-05 | 839 | 31 | 7 | M2099 | |
| Coexpression | GSE6259_BCELL_VS_CD4_TCELL_UP | 7.52e-05 | 192 | 31 | 4 | M6732 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 7.77e-05 | 70 | 31 | 3 | M40002 | |
| Coexpression | LIN_APC_TARGETS | 8.11e-05 | 71 | 31 | 3 | M17434 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 8.47e-05 | 198 | 31 | 4 | M3171 | |
| Coexpression | GSE17721_LPS_VS_CPG_24H_BMDC_DN | 8.81e-05 | 200 | 31 | 4 | M4011 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 8.81e-05 | 200 | 31 | 4 | M5781 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 8.81e-05 | 200 | 31 | 4 | M5926 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP | 8.81e-05 | 200 | 31 | 4 | M7805 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_GRANULOCYTE_AGEING | 1.36e-04 | 224 | 31 | 4 | MM3836 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_THYMOCYTE_AGEING | 1.49e-04 | 701 | 31 | 6 | MM3849 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 1.61e-04 | 444 | 31 | 5 | M41713 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 1.69e-04 | 1399 | 31 | 8 | M535 | |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_SECRETORY_CELL_AGEING | 1.91e-04 | 734 | 31 | 6 | MM3740 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 2.32e-04 | 761 | 31 | 6 | M11961 | |
| Coexpression | TOMIDA_METASTASIS_UP | 4.32e-04 | 26 | 31 | 2 | M17830 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 4.36e-04 | 304 | 31 | 4 | M39208 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS | 4.69e-04 | 310 | 31 | 4 | M41748 | |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_UP | 4.73e-04 | 561 | 31 | 5 | M1463 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 4.75e-04 | 311 | 31 | 4 | M40024 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 5.82e-04 | 904 | 31 | 6 | M2325 | |
| Coexpression | WELCSH_BRCA1_TARGETS_DN | 6.13e-04 | 141 | 31 | 3 | M2428 | |
| Coexpression | LEE_BMP2_TARGETS_DN | 6.46e-04 | 922 | 31 | 6 | MM1068 | |
| Coexpression | LIU_BREAST_CANCER | 6.57e-04 | 32 | 31 | 2 | M16584 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_EPIDERMAL_CELL_AGEING | 7.33e-04 | 618 | 31 | 5 | MM3829 | |
| Coexpression | TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL | 7.94e-04 | 629 | 31 | 5 | M41652 | |
| Coexpression | FISCHER_DREAM_TARGETS | 8.37e-04 | 969 | 31 | 6 | M149 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_UP | 8.85e-04 | 160 | 31 | 3 | M2976 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 1.01e-03 | 1394 | 31 | 7 | M9585 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.04e-03 | 384 | 31 | 4 | M1865 | |
| Coexpression | HSIAO_HOUSEKEEPING_GENES | 1.18e-03 | 397 | 31 | 4 | M11197 | |
| Coexpression | GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP | 1.20e-03 | 178 | 31 | 3 | M5639 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP | 1.22e-03 | 179 | 31 | 3 | M8828 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.24e-03 | 402 | 31 | 4 | MM1248 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN | 1.24e-03 | 1045 | 31 | 6 | M8525 | |
| Coexpression | LEE_LIVER_CANCER_SURVIVAL_DN | 1.24e-03 | 180 | 31 | 3 | M7987 | |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_INTESTINAL_CRYPT_STEM_CELL_AGEING | 1.25e-03 | 403 | 31 | 4 | MM3738 | |
| Coexpression | MTOR_UP.V1_DN | 1.28e-03 | 182 | 31 | 3 | M2670 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 1.31e-03 | 408 | 31 | 4 | M11891 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_UP | 1.33e-03 | 410 | 31 | 4 | M4399 | |
| Coexpression | NUTT_GBM_VS_AO_GLIOMA_DN | 1.36e-03 | 46 | 31 | 2 | M2577 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 1.37e-03 | 186 | 31 | 3 | M4911 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 1.39e-03 | 415 | 31 | 4 | MM1028 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP | 1.42e-03 | 47 | 31 | 2 | M13831 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 1.45e-03 | 190 | 31 | 3 | MM3832 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 1.52e-03 | 193 | 31 | 3 | M3303 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_MONOCYTE_PROGENITOR_CELL_AGEING | 1.52e-03 | 193 | 31 | 3 | MM3797 | |
| Coexpression | BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS | 1.54e-03 | 194 | 31 | 3 | M40026 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.58e-03 | 734 | 31 | 5 | M3835 | |
| Coexpression | GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN | 1.61e-03 | 197 | 31 | 3 | M4157 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.61e-03 | 432 | 31 | 4 | M41149 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP | 1.63e-03 | 198 | 31 | 3 | M5573 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN | 1.63e-03 | 198 | 31 | 3 | M6068 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_DC_UP | 1.66e-03 | 199 | 31 | 3 | M5145 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 1.66e-03 | 199 | 31 | 3 | M8974 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 1.66e-03 | 199 | 31 | 3 | M7656 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 1.66e-03 | 199 | 31 | 3 | M9238 | |
| Coexpression | GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP | 1.66e-03 | 199 | 31 | 3 | M6183 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 1.66e-03 | 199 | 31 | 3 | M3186 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 1.68e-03 | 200 | 31 | 3 | M9456 | |
| Coexpression | GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP | 1.68e-03 | 200 | 31 | 3 | M5102 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN | 1.68e-03 | 200 | 31 | 3 | M8966 | |
| Coexpression | GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN | 1.68e-03 | 200 | 31 | 3 | M5837 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN | 1.68e-03 | 200 | 31 | 3 | M3676 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN | 1.68e-03 | 200 | 31 | 3 | M8319 | |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN | 1.68e-03 | 200 | 31 | 3 | M8327 | |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN | 1.68e-03 | 200 | 31 | 3 | M5364 | |
| Coexpression | GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP | 1.68e-03 | 200 | 31 | 3 | M5723 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 1.68e-03 | 200 | 31 | 3 | M5777 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP | 1.68e-03 | 200 | 31 | 3 | M8290 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN | 1.68e-03 | 200 | 31 | 3 | M6039 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN | 1.68e-03 | 200 | 31 | 3 | M4386 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP | 1.68e-03 | 200 | 31 | 3 | M3470 | |
| Coexpression | GARY_CD5_TARGETS_DN | 1.72e-03 | 440 | 31 | 4 | M13893 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 1.84e-03 | 448 | 31 | 4 | MM1044 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 179 | 32 | 5 | fc9f44fb81da0d381a5141a95a005e66a0be28cc | |
| ToppCell | facs-Bladder-nan-24m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 179 | 32 | 5 | 9152d92bb96e65d43de54e933494f0d08ae02c4f | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.73e-07 | 196 | 32 | 5 | f90e7fe3a7b2fff30d01a25cc500876861c2e4f1 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.73e-07 | 196 | 32 | 5 | 4e97010185fa9392da8f69e7b2a7395bf063f8ff | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 2.94e-07 | 199 | 32 | 5 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 3'-GW_trimst-1|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-07 | 199 | 32 | 5 | ecfb6381e2971a3e355e661a6df0021914485e74 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.69e-06 | 136 | 32 | 4 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.69e-06 | 136 | 32 | 4 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | facs-MAT-Fat-24m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-06 | 156 | 32 | 4 | 7433c6d4eb4d061844d8979c1e648d8ed56e1073 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.16e-06 | 180 | 32 | 4 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.69e-06 | 188 | 32 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 9.89e-06 | 189 | 32 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-06 | 189 | 32 | 4 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.05e-05 | 192 | 32 | 4 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | mild_COVID-19|World / disease group, cell group and cell class (v2) | 1.12e-05 | 195 | 32 | 4 | 6dbe9db5f0e94f2e91b3d1282855d200051ab0ba | |
| ToppCell | NS-critical-d_16-33-Lymphoid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-05 | 197 | 32 | 4 | c6c33f8e2cfd4c6853e77bc3ad334ae41069758c | |
| ToppCell | (08)_Brush+PNEC-(0)_Reference|(08)_Brush+PNEC / shred by cell type by condition | 1.16e-05 | 197 | 32 | 4 | d500bfed2a76f7300f2f17b60962c18a40efd084 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-05 | 198 | 32 | 4 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 198 | 32 | 4 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 199 | 32 | 4 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | C_03|World / shred on cell type and cluster | 1.21e-05 | 199 | 32 | 4 | 1ae1c7152a49a5484e715a1e084f6e02bdbcaca3 | |
| ToppCell | myeloid-Dendritic_cell|myeloid / Lineage, cell class and subclass | 1.21e-05 | 199 | 32 | 4 | b81c0a40481f1006ac4aa8759af95448cb5fc2e6 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.21e-05 | 199 | 32 | 4 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.21e-05 | 199 | 32 | 4 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|myeloid / Lineage, cell class and subclass | 1.21e-05 | 199 | 32 | 4 | 1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5 | |
| ToppCell | NS-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 199 | 32 | 4 | e2d0346cc0c45253b1f958e11263f45e09fd38cb | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 1.21e-05 | 199 | 32 | 4 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | HSPCs|World / Lineage and Cell class | 1.21e-05 | 199 | 32 | 4 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 200 | 32 | 4 | 4234bdc70a9941d4bf77148d75bd271e0c114b88 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.24e-05 | 200 | 32 | 4 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.24e-05 | 200 | 32 | 4 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | wk_08-11|World / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 200 | 32 | 4 | aa35c33762880a5e030a7e691c425524f7dbff8a | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-H|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.24e-05 | 200 | 32 | 4 | 0ebc54d19873a2b7b6d12b81559cb12abd73b90c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 200 | 32 | 4 | ed941933457f8bf63b277025286ef0485e78f4d0 | |
| ToppCell | Sepsis-Bac-SEP|Sepsis / Disease, condition lineage and cell class | 1.24e-05 | 200 | 32 | 4 | 1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.56e-05 | 124 | 32 | 3 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | pdx-Tumor_cells-T4|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.74e-04 | 152 | 32 | 3 | 7ccc56b79c499dd48dab8e2d936edca5223b9356 | |
| ToppCell | (03)_Secretory-(3)_72hpi|(03)_Secretory / shred by cell type and Timepoint | 1.96e-04 | 158 | 32 | 3 | 20563d03183b63aafc9c389f3f03781140702249 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.14e-04 | 163 | 32 | 3 | c1a98d6776b685f20dde049715233e5c73ce3244 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 167 | 32 | 3 | 9a8e291c082d7c26bab21df77bd36ce927032a70 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 169 | 32 | 3 | 0054f9bfd4d377c7fd94873c1308622051c59a8e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.51e-04 | 172 | 32 | 3 | bd01b39a5699824ab14827cc9dc98e547d65b160 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 174 | 32 | 3 | 911eac6f6ec1e5e85348a7fe774243498388a810 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-04 | 179 | 32 | 3 | b70509288aaf4457afd350f6c45784521337ce0d | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 75340f0c06977c88f9d2e56265f4aa84d706d2c6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.96e-04 | 182 | 32 | 3 | f549b986caebc5eb1b2d12f34fe33087e8324a31 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 268fc48ffd88e19c9dcd1af32b635256fc915742 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 183 | 32 | 3 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-04 | 184 | 32 | 3 | 780d67f04fc795f614e077d8a5cf368542f6d99d | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte-MOP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.11e-04 | 185 | 32 | 3 | d1c4fc794c2bd8187abf8f45dc76ba474c40daae | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-04 | 185 | 32 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | facs-Thymus-Flowthrough-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 202e1514954a5a654f7588bed72cd12db513bb19 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 8589d55f7f778442bf31cd4eb1fdaa632f1b7ab0 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 186 | 32 | 3 | e265aac37f33947ff6c83f23f8a2c63bbccd60af | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 187 | 32 | 3 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 37 | 32 | 2 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | Calu_3-infected-SARSCoV1|infected / Cell line, Condition and Strain | 3.26e-04 | 188 | 32 | 3 | a689d59555ecf10bf88c886197d4f7bf9be6c586 | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.36e-04 | 190 | 32 | 3 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | H1299-infected-SARSCoV1|infected / Cell line, Condition and Strain | 3.36e-04 | 190 | 32 | 3 | f7bfeefc0f30f81710a5ddd979f19b0c910c4a42 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-GC_B_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-04 | 190 | 32 | 3 | e04a308d5bf657fd7034e3d2dca425a801ed2bcb | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.36e-04 | 190 | 32 | 3 | 9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | eec14997d2bfc7e6b5a601afc43a147f6b96d668 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 1730ec5dc1cfd2f0cba7e21555641c7bce97e09d | |
| ToppCell | facs-Thymus-Epithelium-24m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 191 | 32 | 3 | 4b77abc68bd72c64e7062f9527fe9d9605289ceb | |
| ToppCell | critical-Lymphoid-B_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.41e-04 | 191 | 32 | 3 | 0716cfaeb11d9c90c18fa8f9d50c9c6fb5182848 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-04 | 191 | 32 | 3 | 4180521a8c5e0ad629cacdd22dc6a94e94b28816 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-04 | 192 | 32 | 3 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.46e-04 | 192 | 32 | 3 | cb6f42dcffe650f7958543531d8f5412b2f2eb12 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-04 | 192 | 32 | 3 | 348d39da3016dc6dbfa65d108e5def35aa7f19dd | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.46e-04 | 192 | 32 | 3 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-04 | 193 | 32 | 3 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.52e-04 | 193 | 32 | 3 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | PBMC-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 3.57e-04 | 194 | 32 | 3 | b903e23eb75733ca516770727097fe74a9f8c1d1 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.57e-04 | 194 | 32 | 3 | 7ad255fa357d41fe57ed803314de46a6577a1283 | |
| ToppCell | Control-B_naive-2|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.62e-04 | 195 | 32 | 3 | 50b1795eb37551777db13b8e9d2df1ef020bfa13 | |
| ToppCell | facs-Thymus-Epithelium-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 195 | 32 | 3 | cc89261bb091ef978bd73cffc68ccdd00a8786d1 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-04 | 195 | 32 | 3 | 1ce4c9ab82212f399ddba9784d2bcec70b6b98b2 | |
| ToppCell | NS-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-04 | 195 | 32 | 3 | 1c0d8dbe8490c35903061469e395b218416b1aa2 | |
| ToppCell | 390C|World / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 195 | 32 | 3 | b955e83c2bf7a7e20ee50fab9dc9678f36d5bfd6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 196 | 32 | 3 | fd0a2b863dedaf08d18e7f67da18ac7e853991e4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.68e-04 | 196 | 32 | 3 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | 15-Distal|15 / Age, Tissue, Lineage and Cell class | 3.68e-04 | 196 | 32 | 3 | 06389b8fb0cd744326ba0523483f742215b6e57b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 3.68e-04 | 196 | 32 | 3 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.68e-04 | 196 | 32 | 3 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.68e-04 | 196 | 32 | 3 | 74093f85e095606d1c723e0d7c2d78d9cfa47c4f | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.73e-04 | 197 | 32 | 3 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 197 | 32 | 3 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.73e-04 | 197 | 32 | 3 | 284008c2d12d6140919b4b3a694652ab356fc81f | |
| ToppCell | normal|World / PBMC cell types (v2) per disease, treatment status, and sex | 3.73e-04 | 197 | 32 | 3 | 232e48864aeb5ad6688352383427fb1771986ddc | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 197 | 32 | 3 | 5f6fce382f273e789ffbb75b63e9b4e87519918e | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 3.73e-04 | 197 | 32 | 3 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| Computational | Genes in the cancer module 32. | 7.67e-10 | 241 | 23 | 9 | MODULE_32 | |
| Computational | RNA splicing. | 3.60e-09 | 65 | 23 | 6 | MODULE_183 | |
| Computational | Neighborhood of FBL | 1.13e-08 | 140 | 23 | 7 | MORF_FBL | |
| Computational | Neighborhood of UBE2I | 1.89e-08 | 238 | 23 | 8 | MORF_UBE2I | |
| Computational | Neighborhood of APEX1 | 2.99e-08 | 92 | 23 | 6 | GNF2_APEX1 | |
| Computational | Neighborhood of ANP32B | 1.24e-07 | 198 | 23 | 7 | MORF_ANP32B | |
| Computational | Neighborhood of DEK | 8.72e-07 | 264 | 23 | 7 | MORF_DEK | |
| Computational | Neighborhood of G22P1 | 1.24e-06 | 172 | 23 | 6 | MORF_G22P1 | |
| Computational | Neighborhood of EIF3S6 | 4.96e-06 | 122 | 23 | 5 | MORF_EIF3S6 | |
| Computational | Neighborhood of SMC1L1 | 8.18e-06 | 62 | 23 | 4 | MORF_SMC1L1 | |
| Computational | Neighborhood of DDX5 | 9.89e-06 | 65 | 23 | 4 | GCM_DDX5 | |
| Computational | Neighborhood of CUL1 | 1.49e-05 | 72 | 23 | 4 | MORF_CUL1 | |
| Computational | Neighborhood of KPNB1 | 1.57e-05 | 73 | 23 | 4 | GNF2_KPNB1 | |
| Computational | Neighborhood of RAN | 1.60e-05 | 268 | 23 | 6 | MORF_RAN | |
| Computational | Neighborhood of BUB3 | 1.94e-05 | 277 | 23 | 6 | MORF_BUB3 | |
| Computational | Neighborhood of CTBP1 | 2.35e-05 | 168 | 23 | 5 | MORF_CTBP1 | |
| Computational | Neighborhood of CSNK2B | 2.37e-05 | 287 | 23 | 6 | MORF_CSNK2B | |
| Computational | Neighborhood of PCNA | 2.62e-05 | 83 | 23 | 4 | MORF_PCNA | |
| Computational | Neighborhood of UBE2N | 4.46e-05 | 95 | 23 | 4 | MORF_UBE2N | |
| Computational | Neighborhood of TDG | 5.36e-05 | 35 | 23 | 3 | GNF2_TDG | |
| Computational | Neighborhood of RAD23A | 6.98e-05 | 348 | 23 | 6 | MORF_RAD23A | |
| Computational | Neighborhood of ACP1 | 7.01e-05 | 211 | 23 | 5 | MORF_ACP1 | |
| Computational | Neighborhood of DAP3 | 1.07e-04 | 119 | 23 | 4 | GNF2_DAP3 | |
| Computational | Neighborhood of PPP2CA | 1.47e-04 | 129 | 23 | 4 | MORF_PPP2CA | |
| Computational | Neighborhood of AP3D1 | 1.51e-04 | 130 | 23 | 4 | MORF_AP3D1 | |
| Computational | Neighborhood of DENR | 1.67e-04 | 51 | 23 | 3 | GNF2_DENR | |
| Computational | Neighborhood of HDAC1 | 1.68e-04 | 254 | 23 | 5 | MORF_HDAC1 | |
| Computational | Neighborhood of FBL | 2.37e-04 | 146 | 23 | 4 | GNF2_FBL | |
| Computational | Neighborhood of DEK | 2.45e-04 | 58 | 23 | 3 | GNF2_DEK | |
| Computational | Neighborhood of SOD1 | 2.56e-04 | 278 | 23 | 5 | MORF_SOD1 | |
| Computational | Neighborhood of GNB1 | 3.93e-04 | 305 | 23 | 5 | MORF_GNB1 | |
| Computational | Neighborhood of PPP1CA | 4.04e-04 | 168 | 23 | 4 | MORF_PPP1CA | |
| Computational | Neighborhood of RBBP6 | 4.27e-04 | 70 | 23 | 3 | GNF2_RBBP6 | |
| Computational | Neighborhood of NPM1 | 4.64e-04 | 72 | 23 | 3 | GNF2_NPM1 | |
| Computational | Neighborhood of HAT1 | 4.72e-04 | 175 | 23 | 4 | MORF_HAT1 | |
| Computational | Neighborhood of CCNI | 8.34e-04 | 88 | 23 | 3 | MORF_CCNI | |
| Computational | Neighborhood of SKP1A | 8.40e-04 | 204 | 23 | 4 | MORF_SKP1A | |
| Computational | Transcription. | 1.07e-03 | 96 | 23 | 3 | MODULE_124 | |
| Computational | Neighborhood of CSNK2B | 1.17e-03 | 99 | 23 | 3 | GCM_CSNK2B | |
| Computational | Neighborhood of XRCC5 | 1.42e-03 | 235 | 23 | 4 | MORF_XRCC5 | |
| Computational | Neighborhood of HDAC1 | 1.59e-03 | 110 | 23 | 3 | GNF2_HDAC1 | |
| Computational | Neighborhood of RAF1 | 1.63e-03 | 111 | 23 | 3 | MORF_RAF1 | |
| Computational | Neighborhood of EIF3S2 | 1.68e-03 | 246 | 23 | 4 | MORF_EIF3S2 | |
| Computational | Neighborhood of PSMC2 | 1.81e-03 | 115 | 23 | 3 | MORF_PSMC2 | |
| Computational | Neighborhood of ACTG1 | 2.24e-03 | 124 | 23 | 3 | GCM_ACTG1 | |
| Computational | Neighborhood of ANP32B | 2.64e-03 | 36 | 23 | 2 | GCM_ANP32B | |
| Computational | Neighborhood of MAP2K2 | 2.68e-03 | 132 | 23 | 3 | MORF_MAP2K2 | |
| Computational | Neighborhood of HDAC2 | 2.70e-03 | 280 | 23 | 4 | MORF_HDAC2 | |
| Computational | Neighborhood of RAD21 | 2.79e-03 | 37 | 23 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of ANP32B | 2.79e-03 | 37 | 23 | 2 | GNF2_ANP32B | |
| Computational | Neighborhood of RAF1 | 3.75e-03 | 43 | 23 | 2 | GCM_RAF1 | |
| Computational | Neighborhood of UBE2I | 3.92e-03 | 44 | 23 | 2 | GNF2_UBE2I | |
| Computational | Neighborhood of ELAC2 | 4.28e-03 | 46 | 23 | 2 | GNF2_ELAC2 | |
| Computational | Genes in the cancer module 83. | 4.36e-03 | 320 | 23 | 4 | MODULE_83 | |
| Computational | Neighborhood of FEN1 | 6.29e-03 | 56 | 23 | 2 | GNF2_FEN1 | |
| Computational | Neighborhood of RAD21 | 6.39e-03 | 180 | 23 | 3 | MORF_RAD21 | |
| Computational | Neighborhood of MCM5 | 7.42e-03 | 61 | 23 | 2 | GNF2_MCM5 | |
| Computational | Neighborhood of RPA1 | 7.42e-03 | 61 | 23 | 2 | MORF_RPA1 | |
| Computational | Neighborhood of MSH2 | 7.42e-03 | 61 | 23 | 2 | MORF_MSH2 | |
| Computational | Neighborhood of ESPL1 | 7.42e-03 | 61 | 23 | 2 | MORF_ESPL1 | |
| Computational | Neighborhood of SART1 | 7.90e-03 | 63 | 23 | 2 | MORF_SART1 | |
| Computational | Neighborhood of DAP3 | 7.97e-03 | 195 | 23 | 3 | MORF_DAP3 | |
| Computational | Neighborhood of ST13 | 8.15e-03 | 64 | 23 | 2 | GNF2_ST13 | |
| Computational | Neighborhood of FEN1 | 8.39e-03 | 65 | 23 | 2 | MORF_FEN1 | |
| Computational | Neighborhood of TERF1 | 8.90e-03 | 67 | 23 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of AATF | 9.63e-03 | 209 | 23 | 3 | MORF_AATF | |
| Computational | Neighborhood of CDK2 | 1.02e-02 | 72 | 23 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of XRCC5 | 1.11e-02 | 75 | 23 | 2 | GNF2_XRCC5 | |
| Computational | Neighborhood of SP3 | 1.22e-02 | 79 | 23 | 2 | MORF_SP3 | |
| Computational | TFs and nuclear. | 1.35e-02 | 237 | 23 | 3 | MODULE_252 | |
| Computational | Neighborhood of SMC4L1 | 1.37e-02 | 84 | 23 | 2 | GNF2_SMC4L1 | |
| Computational | Neighborhood of PSME1 | 1.40e-02 | 85 | 23 | 2 | GCM_PSME1 | |
| Computational | Neighborhood of PRDX3 | 1.40e-02 | 85 | 23 | 2 | MORF_PRDX3 | |
| Drug | U1-6 | 3.12e-05 | 45 | 31 | 3 | CID006914648 | |
| Drug | AC1MJ6CJ | 3.75e-05 | 7 | 31 | 2 | CID003086525 | |
| Drug | U1 3 | 4.29e-05 | 50 | 31 | 3 | CID011840989 | |
| Drug | AC1NRA5C | 8.82e-05 | 174 | 31 | 4 | CID005287709 | |
| Drug | DB08668 | 9.43e-05 | 65 | 31 | 3 | CID011840990 | |
| Drug | U-17 | 9.87e-05 | 66 | 31 | 3 | CID011840991 | |
| Drug | pyranine | 1.17e-04 | 12 | 31 | 2 | CID000061388 | |
| Drug | AC1L1DSW | 1.18e-04 | 70 | 31 | 3 | CID000002493 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 1.50e-05 | 6 | 30 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | uterine prolapse | 1.19e-04 | 16 | 30 | 2 | EFO_1001864 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.28e-04 | 145 | 30 | 3 | DOID:1289 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms, Experimental | 5.20e-04 | 155 | 30 | 3 | C0024668 | |
| Disease | myopathy (implicated_via_orthology) | 1.09e-03 | 48 | 30 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.18e-03 | 206 | 30 | 3 | C0152013 | |
| Disease | Amyotrophic Lateral Sclerosis | 1.59e-03 | 58 | 30 | 2 | C0002736 | |
| Disease | fish consumption measurement | 1.94e-03 | 64 | 30 | 2 | EFO_0010139 | |
| Disease | skin neoplasm | 2.58e-03 | 74 | 30 | 2 | EFO_0004198 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.48e-03 | 301 | 30 | 3 | DOID:684 (is_marker_for) | |
| Disease | HIV Coinfection | 4.93e-03 | 103 | 30 | 2 | C4505456 | |
| Disease | HIV Infections | 4.93e-03 | 103 | 30 | 2 | C0019693 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NQAHGKGGHRGGGGG | 61 | Q07065 | |
| GGRGHGGGRHGPAGT | 51 | P54253 | |
| RSGSGNFGGGRGGGF | 151 | A0A2R8Y4L2 | |
| RGGGFGGNDNFGRGG | 161 | A0A2R8Y4L2 | |
| NFSGRGGFGGSRGGG | 176 | A0A2R8Y4L2 | |
| GSGGGGHRDGRGTGD | 61 | Q8NDT2 | |
| ARGTRGGGFGAHGRG | 86 | P98179 | |
| GGGRGSRGSAGGHGS | 16 | Q15056 | |
| RNGQAGGGGGGGSAH | 266 | O14649 | |
| GERGGFRGGRGGAHR | 436 | Q9HCE5 | |
| SRSGGGGGGGFGRVS | 36 | P13647 | |
| GKGGFGARARGFGGG | 46 | A6NHQ2 | |
| GGGRGGGGFHSGGNR | 56 | P22087 | |
| GGGFHSGGNRGRGRG | 61 | P22087 | |
| GRADDGGGGGGFHAR | 101 | Q03052 | |
| GSGRGRGRGQGQGRG | 436 | B2RXH2 | |
| PHRSRGGGGGSRGGA | 41 | Q07666 | |
| GGNRGGFQNRGGGSG | 636 | Q9BUJ2 | |
| HGSGGGQRPGGGHGS | 556 | O14654 | |
| MSFRGGGRGGFNRGG | 1 | Q9NY12 | |
| FNRGGGGGGFNRGGS | 11 | Q9NY12 | |
| NRGGSSNHFRGGGGG | 21 | Q9NY12 | |
| RGGFGRGGGRGGFNK | 46 | Q9NY12 | |
| GNRNRGNRGSGGGGG | 246 | Q99729 | |
| QGGFGNSRGGGAGLG | 286 | Q13148 | |
| QGGGRGGRGGYDHGG | 356 | Q8NCA5 | |
| QGSGGGAGRGHGRRG | 331 | Q7Z4P5 | |
| RGDDGRGGGTGGPNH | 1061 | P48634 | |
| GSAGGRGFFRGGRGR | 96 | Q14011 | |
| RSGFGGSGGGRGGAS | 31 | Q9UKZ1 | |
| FRSRGGGGGGFHRRG | 6 | P23246 | |
| FHRRGGGGGRGGLHD | 16 | P23246 | |
| SGGGGGGSRSSRGGR | 181 | Q13151 | |
| RNGGGGGGGGSGLHC | 16 | Q96L92 | |
| RGGGGGGLGNNGSSR | 126 | Q96DT7 | |
| RSGSGNFGGGRGGGF | 196 | P09651 | |
| RGGGFGGNDNFGRGG | 206 | P09651 | |
| NFSGRGGFGGSRGGG | 221 | P09651 | |
| RGHDGPGHGGGGHRG | 881 | Q96QC0 | |
| TRNRGAGGFGGGGGT | 201 | Q86V81 | |
| AGGFGGGGGTRRGTR | 206 | Q86V81 | |
| RGRCGGGGYGIHGRG | 41 | Q7Z794 | |
| RGGGARGRSGGGYGS | 526 | Q7Z794 |